Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus

Directly acting antivirals recently have become available for the treatment of hepatitis C virus (HCV) infection, but there is no prophylactic vaccine for HCV. In the present study, we took advantage of the properties of Japanese encephalitis virus (JEV) to develop antigens for use in a HCV vaccine....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Saga, Ryohei, Fujimoto, Akira, Watanabe, Noriyuki, Matsuda, Mami, Hasegawa, Makoto, Watashi, Koichi, Aizaki, Hideki, Nakamura, Noriko, Tajima, Shigeru, Takasaki, Tomohiko, Konishi, Eiji, Kato, Takanobu, Kohara, Michinori, Takeyama, Haruko, Wakita, Takaji, Suzuki, Ryosuke
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4922013/
https://ncbi.nlm.nih.gov/pubmed/27345289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep28688
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados